Humacyte, Inc. (HUMA) vs Voyager Therapeutics, Inc. (VYGR)
Humacyte, Inc. and Voyager Therapeutics, Inc. are both Biotechnology companies. Humacyte, Inc. and Voyager Therapeutics, Inc. are of similar size ($172.5M and $166.7M). Humacyte, Inc. grew revenue faster over the last twelve months: 149.8% against −19.1%. Voyager Therapeutics, Inc. has the higher net margin (−312.6% vs −4,448.9%) and the higher return on invested capital (−192.6% vs −433.7%). Across the 17 metrics below, Voyager Therapeutics, Inc. leads on 13 and Humacyte, Inc. on 4.
Valuation
Profitability
| Metric | HUMA | VYGR | Biotechnology median |
|---|---|---|---|
| Gross margin | (494.58%) | 100.00% | 65.16% |
| Operating margin | (5,240.78%) | (340.08%) | 0.00% |
| Net margin | (4,448.89%) | (312.63%) | 0.00% |
| Free cash flow margin | (4,599.72%) | (352.36%) | 0.00% |
| Return on equity | (534.42%) | (54.09%) | (57.72%) |
| Return on assets | (68.16%) | (41.45%) | (49.22%) |
| Return on invested capital | (433.66%) | (192.55%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack